Australia’s Adamantem Capital has agreed to sell its position local data analytics consultancy Servian to US counterpart Cognizant for an undisclosed sum.
This is Adamantem’s first exit from Fund I, which closed at A$608 million ($468 million) in 2018 and targets companies with enterprise valuations in a range of A$100-500 million. It backed Servian in...
SciClone Pharmaceuticals, a Chinese drug developer privatized by a PE consortium at a valuation of $605 million in 2017, has relisted in Hong Kong and ended its first day of trading with a market capitalization of HK$12.7 billion ($1.64 billion).
Iluvatar CoreX, a Shanghai-based computing chip designer has raised RMB1.2 billion ($186 million) in Series C funding led by Cedarlake Capital and Centurium Capital.
China’s less-than-truckload logistics market, which sits in between express couriers and big truck operators, is ripe for consolidation. GPs have identified their favored players
US-based Platinum Equity has exited its control position in Sensis, best known as the operator of Australia’s White Pages and Yellow Pages directories, in a deal worth $200 million.